Literature DB >> 8221268

Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.

P W Ewan1, J Deighton, A B Wilson, P J Lachmann.   

Abstract

This paper investigates the relationship between venom IgG levels and protection from stings. Venom-specific IgG antibody levels have been measured by radioimmunoassay in untreated wasp-(n = 38) and bee-allergic (n = 16) patients presenting with systemic reactions to stings and in a sub-group of these (wasp = 15; bee = 9), before and after the initial course of venom immunotherapy (VIT). A history was taken of all reactions, the last systemic reaction being graded on a scale of 1-8 and of the number and timing of stings. In untreated patients venom IgG levels were much higher in bee-allergic patients (mean +/- s.e. = 68.2 +/- 7.1% positive pool) than in the wasp group (27.1 +/- 4.2%) (P < 0.05 Mann-Whitney U-test). There was a marked rise in venom IgG after the initial course of VIT in the wasp group (geometric mean and 95% confidence intervals = 40.5%, 28.8-54.3) but a much smaller rise in the bee group (15.3%, 6.6-24.1), with no overlap in the 95% confidence intervals. Bee patients, who were mainly beekeepers or their relatives, had been more heavily immunized with venom than wasp patients. They had received: (i) more stings (mean number of stings: bee, 26; wasp, 4; P < 0.001) and (ii) more stings per year. Wasp patients received their smaller number of stings over a much longer period, up to 40 yr. There was no correlation between the severity of the last systemic reaction and the venom IgG levels alone or venom IgG and IgE levels in combined analysis in either bee or wasp patients. This study shows that the pattern of IgG response differs in bee and wasp-allergic subjects, and that most bee-allergic subjects with systemic reactions have high levels of venom IgG. The degree of immunization with venom seems to be an important determinant of the venom IgG level. Our findings suggest that venom-specific IgG levels do not predict systemic reactions to stings and are not useful for monitoring VIT. If protection from stings is IgG-mediated, our observations suggest that the relevant immune response is more complex, possibly involving IgG sub-classes, IgG antibodies to individual venom antigens or antibody affinity, and not adequately reflected by measurement of the concentration of venom-specific IgG.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221268     DOI: 10.1111/j.1365-2222.1993.tb01791.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

1.  IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.

Authors:  Richard T Strait; Suzanne C Morris; Fred D Finkelman
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

Review 2.  [Immunologic control parameters during specific immunotherapy].

Authors:  H Ott; M Wosnitza; H F Merk
Journal:  Hautarzt       Date:  2008-07       Impact factor: 0.751

Review 3.  [Diagnosis and treatment of insect venom allergy. An important allergic issue for the ear, nose and throat specialist].

Authors:  O Pfaar; L Klimek; I Hansen; B A Stuck; K Hörmann
Journal:  HNO       Date:  2005-12       Impact factor: 1.284

Review 4.  Clinical immunology review series: an approach to desensitization.

Authors:  M T Krishna; A P Huissoon
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

Review 5.  [Insect venom allergies : Update 2016 for otorhinolaryngologists].

Authors:  L Klimek; N Dippold; A Sperl
Journal:  HNO       Date:  2016-12       Impact factor: 1.284

Review 6.  Novel developments in the mechanisms of immune tolerance to allergens.

Authors:  Thomas Eiwegger; Saskia Gruber; Zsolt Szépfalusi; Cezmi A Akdis
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

7.  The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.

Authors:  Mohamed H Shamji; Louisa K Wilcock; Petra A Wachholz; Rebecca J Dearman; Ian Kimber; Peter A Wurtzen; Mark Larché; Stephen R Durham; James N Francis
Journal:  J Immunol Methods       Date:  2006-10-05       Impact factor: 2.303

8.  Congruence of the current practices in Hymenoptera venom allergic patients in Poland with EAACI guidelines.

Authors:  Ewa Cichocka-Jarosz; Lavanya Diwakar; Piotr Brzyski; Beata Tobiasz-Adamczyk; Grzegorz Lis; Jacek J Pietrzyk
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

9.  Oral mucosal immunotherapy for allergic rhinitis: A pilot study.

Authors:  William R Reisacher; Maria V Suurna; Kate Rochlin; Maria G Bremberg; Guy Tropper
Journal:  Allergy Rhinol (Providence)       Date:  2016-01

Review 10.  Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.

Authors:  Maximilian Schiener; Anke Graessel; Markus Ollert; Carsten B Schmidt-Weber; Simon Blank
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.